1. Home
  2. HKPD

as 02-14-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Stocks

Health Care

Other Pharmaceuticals

Nasdaq

Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Founded: 2016 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 22.0M IPO Year: 2025
Target Price: N/A AVG Volume (30 days): 488.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.18 EPS Growth: N/A
52 Week Low/High: $1.80 - $3.79 Next Earning Date: 01-01-0001
Revenue: $16,688,364 Revenue Growth: 32.91%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares News

HKPD Breaking Stock News: Dive into HKPD Ticker-Specific Updates for Smart Investing

All HKPD News

Share on Social Networks: